NCT07664449

Brief Summary

Babies in neonatal intensive care units (NICUs) sometimes need help breathing using a breathing tube (endotracheal tube, or ETT) connected to a breathing machine (ventilator). Over time, bacteria and other substances can build up on the inside of these tubes. This build-up may contribute to infections, inflammation, or breathing problems, but we do not fully understand how often this occurs or what is present within the tubes used in UK NICUs. This surveillance study will collect breathing tubes that have been removed from babies who have been ventilated for more than 12 hours as part of their normal clinical care. No additional procedures or interventions will be performed on babies, and the tubes would otherwise be discarded. Researchers will examine the used tubes and any respiratory secretions (mucus) associated with them. Laboratory testing will identify any bacteria or other microorganisms present and analyse the chemical composition that has accumulated within the tubes and respiratory secretions. By studying these samples, we hope to better understand how breathing tubes become colonised over time and how this may relate to infection and lung health in newborn babies. This study aims to identify the microorganisms that colonises ETT and map them in a contemporary UK neonatal cohort. The information gained from this study may help improve infection surveillance, guide future research, and support the development of strategies to reduce complications associated with mechanical ventilation in vulnerable newborn infants.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for all trials

Timeline
19mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress5%
Jul 2026Mar 2028

First Submitted

Initial submission to the registry

June 17, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 24, 2026

Completed
7 days until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2028

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2028

Last Updated

June 24, 2026

Status Verified

June 1, 2026

Enrollment Period

1.5 years

First QC Date

June 17, 2026

Last Update Submit

June 17, 2026

Conditions

Keywords

ventilationendotracheal tube colonisationneonatalbiofilm colonisation

Outcome Measures

Primary Outcomes (1)

  • Microbial biofilm colonisation of ETT

    Mapping common neonatal pathogens involved in microbial colonisation of ETT on NICU

    18 months

Secondary Outcomes (1)

  • Ventilator-associated pneumonia

    18 months

Study Arms (1)

Neonatal patients intubated and mechanically ventilated for more than 12 hours

80 neonatal patients across all gestational ages

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Neonatal infants of all gestational ages

You may qualify if:

  • Infant of any gestational age (22 weeks gestation and upwards) who is expected to be intubated for more than 12 hours
  • All infants must have verbal or written informed consent from the parent/carer
  • All infants must have a realistic prospect of survival as determined by the attending clinical team

You may not qualify if:

  • Infants that are not for active resuscitation
  • Infants that are undergoing end-of-life care
  • In situations where consent is not possible or provided

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITHOUT DNA

Participant biospecimens (endotracheal tube and respiratory secretions) will be retained for microbiological and chemical analyses. These will not be retained following completion of the study analyses. No DNA extraction or genetic analysis will be performed.

MeSH Terms

Conditions

Respiratory Aspiration

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Don Sharkey

    University of Nottingham

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 17, 2026

First Posted

June 24, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

January 1, 2028

Study Completion (Estimated)

March 1, 2028

Last Updated

June 24, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

No, there are no plans to share individual participant data (IPD) with other researchers.